146 related articles for article (PubMed ID: 16393296)
1. Statins and the risk of acute pancreatitis: a population-based case-control study.
Thisted H; Jacobsen J; Munk EM; Nørgaard B; Friis S; McLaughlin JK; Sørensen HT; Johnsen SP
Aliment Pharmacol Ther; 2006 Jan; 23(1):185-90. PubMed ID: 16393296
[TBL] [Abstract][Full Text] [Related]
2. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study.
Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP
Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
[TBL] [Abstract][Full Text] [Related]
4. Metronidazole and risk of acute pancreatitis: a population-based case-control study.
Nørgaard M; Ratanajamit C; Jacobsen J; Skriver MV; Pedersen L; Sørensen HT
Aliment Pharmacol Ther; 2005 Feb; 21(4):415-20. PubMed ID: 15709992
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
[TBL] [Abstract][Full Text] [Related]
6. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study.
Floyd A; Pedersen L; Nielsen GL; Thorlacius-Ussing O; Sorensen HT
Am J Gastroenterol; 2003 Jun; 98(6):1305-8. PubMed ID: 12818274
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotics and risk of first-time hospitalization for myocardial infarction: a population-based case-control study.
Nakagawa S; Pedersen L; Olsen ML; Mortensen PB; Sørensen HT; Johnsen SP
J Intern Med; 2006 Nov; 260(5):451-8. PubMed ID: 17040251
[TBL] [Abstract][Full Text] [Related]
8. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.
Boudreau DM; Gardner JS; Malone KE; Heckbert SR; Blough DK; Daling JR
Cancer; 2004 Jun; 100(11):2308-16. PubMed ID: 15160333
[TBL] [Abstract][Full Text] [Related]
9. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
10. Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis.
Sørensen HT; Jacobsen J; Nørgaard M; Pedersen L; Johnsen SP; Baron JA
Aliment Pharmacol Ther; 2006 Jul; 24(1):111-6. PubMed ID: 16803609
[TBL] [Abstract][Full Text] [Related]
11. The risk of cancer in users of statins.
Graaf MR; Beiderbeck AB; Egberts AC; Richel DJ; Guchelaar HJ
J Clin Oncol; 2004 Jun; 22(12):2388-94. PubMed ID: 15197200
[TBL] [Abstract][Full Text] [Related]
12. Statins and newly diagnosed diabetes.
Jick SS; Bradbury BD
Br J Clin Pharmacol; 2004 Sep; 58(3):303-9. PubMed ID: 15327590
[TBL] [Abstract][Full Text] [Related]
13. Acid-suppressing drugs and gastroesophageal reflux disease as risk factors for acute pancreatitis--results from a Swedish Case-Control Study.
Sundström A; Blomgren K; Alfredsson L; Wiholm BE
Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):141-9. PubMed ID: 16200654
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery.
Noordzij PG; Poldermans D; Schouten O; Schreiner F; Feringa HH; Dunkelgrun M; Kertai MD; Boersma E
Coron Artery Dis; 2007 Feb; 18(1):67-72. PubMed ID: 17172933
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
16. Statin use and risk of colorectal cancer.
Coogan PF; Smith J; Rosenberg L
J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
[TBL] [Abstract][Full Text] [Related]
17. Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans.
Khurana V; Sheth A; Caldito G; Barkin JS
Pancreas; 2007 Mar; 34(2):260-5. PubMed ID: 17312467
[TBL] [Abstract][Full Text] [Related]
18. Statins and prostate cancer risk: a case-control study.
Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE
Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.
Murtola TJ; Tammela TL; Lahtela J; Auvinen A
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910
[TBL] [Abstract][Full Text] [Related]
20. Statin use and risk of lymphoid neoplasms: results from the European Case-Control Study EPILYMPH.
Fortuny J; de Sanjosé S; Becker N; Maynadié M; Cocco PL; Staines A; Foretova L; Vornanen M; Brennan P; Nieters A; Alvaro T; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):921-5. PubMed ID: 16702371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
